title: [Clinical and etiological profile malignant hypertension in children in pediatric intensive care].
abstract: BACKGROUND
  Malignant hypertension (HTA), pediatrics, is unique by its clinical presentation, defined as severe hypertension accompanied by ischemic failure of one or more organs.
  Retroprospective study of cases of children admitted to pediatric intensive care. We chose a decline of 10 years from September 1994 to December 2004 for the first time, and from January 2005 to December 2015 for the second period; and we identified the cases presenting malignant hypertension (mHTA).
  
  
  RESULTS
  Sixty-six patients were included, a prevalence of 0.6%. The age of patients ranged from 12months to 16years. The symptoms are related to the consequences of hypertension or condition in question. The most found signs are headache in more than 7%. Cerebrovascular event in 6%. A hypertensive convulsive encephalopathy 33.3% of patients. Renal disease is common, of varying severity. A fundus retinopathy was found in 47% stage 3, stage 4 in 51%. mHTA defined for the mean SBP values of 175mmHg and DBP average 112,5mmHg is often secondary to renal causes. The treatment is symptomatic with antihypertensive associated with the etiological treatment. Evolution is good out of 7 deaths.
  
  
  CONCLUSIONS
  mHTA is a rare condition in the pediatric population. The clinical signs of functional rich under their impact on vital organs. The support must be early in intensive care.
authors.affiliation: Service de réanimation pédiatrique CHU d'Oran, Oran, Algérie. Electronic address: djamiladbenbat@yahoo.fr.
authors.forename: D-D
authors.initials: DD
authors.lastname: Batouche
authors.affiliation: Service d'immunologie, HMRU Oran, Oran, Algérie.
authors.forename: K E
authors.initials: KE
authors.lastname: Kerboua
authors.affiliation: Service de néphrologie CHU d'Oran, Oran, Algérie.
authors.forename: L
authors.initials: L
authors.lastname: Sadaoui
authors.affiliation: Service de réanimation pédiatrique CHU d'Oran, Oran, Algérie.
authors.forename: F
authors.initials: F
authors.lastname: Benhamed
authors.affiliation: Service de réanimation pédiatrique CHU d'Oran, Oran, Algérie.
authors.forename: S
authors.initials: S
authors.lastname: Zohret-Bouhalouane
authors.affiliation: Service de réanimation pédiatrique CHU d'Oran, Oran, Algérie.
authors.forename: N
authors.initials: N
authors.lastname: Boucherit
authors.affiliation: Service de réanimation pédiatrique CHU d'Oran, Oran, Algérie.
authors.forename: M
authors.initials: M
authors.lastname: Berexi-Reguig
authors.affiliation: Service de réanimation pédiatrique CHU d'Oran, Oran, Algérie.
authors.forename: K
authors.initials: K
authors.lastname: Elhalimi
authors.affiliation: Service de cardiologie, unité enfant, CHU d'Oran, Oran, Algérie.
authors.forename: N-F
authors.initials: NF
authors.lastname: Benatta
mesh_terms: D000293:Adolescent; D000462:Algeria / Q000453:epidemiology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003422:Critical Care / Q000706:statistics & numerical data; D005260:Female; D006261:Headache / Q000209:etiology; D006776:Hospitals, Pediatric; D006801:Humans; D006974:Hypertension, Malignant / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology*; D007223:Infant; D002546:Ischemic Attack, Transient / Q000209:etiology; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D012164:Retinal Diseases / Q000209:etiology; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents
keywords: Child; Encéphalopathie hypertensive convulsivante; Enfant; FO; Fundus; HTA maligne; Hypertensive convulsive encephalopathy; Kidney injury; Lésions rénales; Malignant hypertension